| human | Q5 |
| P6178 | Dimensions author ID | 01361121274.43 |
| P691 | NL CR AUT ID | xx0303688 |
| P496 | ORCID iD | 0000-0003-0994-027X |
| P1153 | Scopus author ID | 36041155600 |
| P214 | VIAF ID | 5797169181072869050007 |
| P101 | field of work | heart disease | Q190805 |
| cardiac surgery | Q235007 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | researcher | Q1650915 |
| surgeon | Q774306 | ||
| P21 | sex or gender | male | Q6581097 |
| Q58972787 | 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention |
| Q37031817 | 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide |
| Q102213686 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines |
| Q102213699 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines |
| Q102334865 | 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines |
| Q56836084 | 40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004 |
| Q61648272 | A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes |
| Q61648520 | A Heart-shaped Mass Inside a Heart: Echocardiographic Diagnosis, Pathology, and Surgical Repair of a Flail Tricuspid Valve Caused by a Large Blood-filled Cyst |
| Q61648750 | A Method for Repair of Aortic Dissection Originating in the Transverse Arch Using Two Sutureless Intraluminal Prostheses |
| Q47923937 | A Multidisciplinary Approach to Ensure Scientific Integrity in Clinical Research |
| Q61648453 | A Novel Method of Leaflet Reconstruction After Triangular Resection for Posterior Mitral Valve Prolapse |
| Q61648451 | A Pilot Study of Electronic Cardiovascular Operative Notes: Qualitative Assessment and Challenges in Implementation |
| Q56987061 | A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations |
| Q92937511 | A Step Back in the Diagnosis and Management of Myocardial Bridging (Reply) |
| Q91316064 | A Symptomatic Calcified Pericardial Cyst |
| Q70393714 | A cost-effective technique for experimental coronary artery bypass |
| Q53774867 | A dangerous myxoma. |
| Q48050152 | A history of innovation: cardiac surgery in Minnesota |
| Q61648592 | A method of repair for asymmetric aneurysmal dilatation of the ascending aorta |
| Q51000630 | A model of heterotopic aortic valve replacement for studying thromboembolism prophylaxis in mechanical valve prostheses. |
| Q61648615 | A model of xenograft hyperacute rejection attenuates endothelial nitric oxide production: a mechanism for graft vasospasm? 11Copyright © 1998 by the Mayo Foundation |
| Q71730418 | A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting |
| Q67817823 | A new method of producing pulsatile flow during cardiopulmonary bypass using a standard roller pump |
| Q44669289 | A novel antioxidant, EPC-K1, stimulates endothelial nitric oxide production and scavenges hydroxyl radicals |
| Q46649535 | A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: should hemodynamic performance influence device selection? |
| Q51152215 | A prospective, randomized platelet-function study of heparinized oxygenators and cardiotomy suction. |
| Q33601226 | A prospective, randomized study of cardiopulmonary bypass temperature and blood transfusion |
| Q48326719 | A prospective, randomized, double-blind trial of 3 regimens for sedation and analgesia after cardiac surgery |
| Q58975787 | ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary |
| Q92855996 | ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison |
| Q58975824 | ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita |
| Q56986832 | ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention |
| Q56986819 | ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article |
| Q56986823 | ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article |
| Q56986829 | ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 |
| Q44372020 | Ablation of atrial fibrillation: comparison of catheter-based techniques and the Cox-Maze III operation |
| Q90832143 | Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy |
| Q61648522 | Accuracy of Roche Accu-Chek Inform Whole Blood Capillary, Arterial, and Venous Glucose Values in Patients Receiving Intensive Intravenous Insulin Therapy After Cardiac Surgery |
| Q37463870 | Achieved anticoagulation vs prosthesis selection for mitral mechanical valve replacement: a population-based outcome study. |
| Q61648292 | Acute Aortic Dissection Extending Into the Lung |
| Q70252126 | Acute Dissecting Aneurysm of the Aorta after Renal Transplantation |
| Q47208628 | Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture |
| Q40267433 | Acute aortitis of the ascending aorta |
| Q45146056 | Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries |
| Q36110654 | Acute renal failure after cardiac surgery for carcinoid heart disease: incidence, risk factors, and prognosis. |
| Q42499900 | Acutely sodded expanded polytetrafluoroethylene grafts produce only prostacyclin: a qualitative difference from saphenous veins. |
| Q91872143 | Adult Intraoperative Echocardiography: A Comprehensive Review of Current Practice |
| Q37857382 | Adult presentation of interrupted aortic arch: case presentation and a review of the medical literature |
| Q37688241 | Adults with Down syndrome: safety and long-term outcome of cardiac operation |
| Q39768160 | Advances in surgical management of congenital heart disease in adults |
| Q45192960 | Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue |
| Q53569736 | Alternative for surgical management of calcific aortic valve stenosis: sutureless valve implants. |
| Q38133652 | American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomogra |
| Q46469454 | Amiodarone causes endothelium-dependent vasodilation in canine coronary arteries |
| Q48148900 | Amiodarone versus lidocaine and placebo for the prevention of ventricular fibrillation after aortic crossclamping: a randomized, double-blind, placebo-controlled trial |
| Q52648722 | An alternate approach to valve replacement in patients with mitral stenosis and severely calcified annulus. |
| Q61648593 | An experimental model of saphenous vein-to-coronary artery anastomosis with the St. Jude medical stainless steel connector |
| Q92060815 | An unusual coronary embolus in a patient with prosthetic endocarditis |
| Q104510608 | An unusual presentation of dyspnea following septal ablation for obstructive hypertrophic cardiomyopathy |
| Q50858538 | Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. |
| Q44592023 | Analysis of benign ventricular tumors: long-term outcome after resection |
| Q61648567 | Anatomical basis for acquired intracardiac shunt postaortic valve replacement: Doppler echocardiographic diagnosis |
| Q48521754 | Anesthetic technique influences brain temperature during cardiopulmonary bypass in dogs |
| Q67653660 | Angiogenic factor: a possible mechanism for neovascularization produced by omental pedicles |
| Q61648787 | Angiographic changes produced by percutaneous transluminal coronary angioplasty |
| Q61648664 | Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI) |
| Q61648785 | Angioplasty in total coronary artery occlusion |
| Q53178509 | Anomalous papillary muscle insertion in hypertrophic cardiomyopathy. |
| Q94947072 | Anomalous papillary muscles-Implications in the surgical treatment of hypertrophic obstructive cardiomyopathy |
| Q43563061 | Anticoagulation early after mechanical valve replacement: improved management with patient self-testing |
| Q33334149 | Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery |
| Q61648353 | Aortic Leaflet Thinning Can Mimick Leaflet Perforation on Transesophageal Echocardiogram |
| Q49035192 | Aortic Root Dilation: Do Patients With Marfan Syndrome Fare Worse Than Those With Marfanoid Features? |
| Q38763643 | Aortic Root Surgery in Marfan Syndrome: Medium-Term Outcome in a Single-Center Experience |
| Q38608211 | Aortic Stenosis and Noncardiac Surgery: Managing the Risk. |
| Q38405812 | Aortic arch surgery after previous type A dissection repair: results up to 5 years |
| Q35169734 | Aortic dissection in pregnancy: analysis of risk factors and outcome. |
| Q39797264 | Aortic dissection with fistula to right atrium. Noninvasive diagnosis by two-dimensional and Doppler echocardiography with successful repair. Case report and review of the literature. |
| Q41057811 | Aortic reconstruction in kidney transplant recipients |
| Q53593055 | Aortic root enlargement in octogenarian patients results in less patient prosthesis mismatch. |
| Q50901289 | Aortic root enlargement: what are the operative risks? |
| Q40382552 | Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results |
| Q38108075 | Aortic valve and ascending aorta guidelines for management and quality measures |
| Q38071821 | Aortic valve and ascending aorta guidelines for management and quality measures: executive summary |
| Q43792134 | Aortic valve decalcification: history repeated with a new result |
| Q61648323 | Aortic valve repair: Defining the patient population and timing of the intervention |
| Q41189739 | Aortic valve replacement after previous coronary artery bypass grafting |
| Q46675385 | Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses |
| Q39465898 | Aortic valve replacement in patients aged eighty years and older: early and long-term results |
| Q49345964 | Aortic valve replacement in patients with amyloidosis |
| Q44921838 | Aortic valve replacement in the elderly: determinants of late outcome |
| Q61648377 | Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement. |
| Q68902846 | Aortico-left ventricular tunnel: diagnosis based on two-dimensional echocardiography, color flow Doppler imaging, and magnetic resonance imaging |
| Q61648632 | Aortocoronary Bypass Grafting With Expanded Polytetrafluoroethylene: 12-Year Patency 11Nothing in this publication implies that Mayo Foundation endorses any product mentioned in this article |
| Q54248882 | Aortopulmonary window: factors associated with early and late success after surgical treatment. |
| Q91749491 | Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure |
| Q33158413 | Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. |
| Q41074800 | Appropriate patient selection or health care rationing? Lessons from surgical aortic valve replacement in the Placement of Aortic Transcatheter Valves I trial |
| Q61648683 | Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function |
| Q41216172 | Are postischemic hearts really stiffer? |
| Q54244415 | Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. |
| Q40639690 | Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial |
| Q37858754 | Ascending-descending posterior pericardial bypass of complex coarctation of the aorta |
| Q48873174 | Ascending-to-descending aortic bypass: a simple solution to a complex problem |
| Q114260805 | Assessing the Impact of Publications: A Bibliometric Analysis of the Top-Cited Articles from The Journal of Thoracic and Cardiovascular Surgery |
| Q51786504 | Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: when is preoperative coronary angiography necessary? |
| Q71612200 | Assessment of myocardial protection during global ischemia with myocardial gas tension monitoring |
| Q46657628 | Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets |
| Q61648481 | Asymptomatic Severe Mitral Valve Regurgitation |
| Q36503664 | Asymptomatic left ventricular systolic dysfunction in patients with severe aortic stenosis: characteristics and outcomes |
| Q73183224 | Asymptomatic occlusion of the left main coronary artery by an aortic pseudoaneurysm |
| Q61648568 | Atrial Fibrillation After Surgical Correction of Mitral Regurgitation in Sinus Rhythm |
| Q71715741 | Augmented endothelium-dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery |
| Q67412162 | Autotransfusion in cardiac surgical patients after operation |
| Q67319850 | Autotransfusion of shed mediastinal blood after cardiac surgery: a prospective study |
| Q96772539 | Bicuspid Aortic Valve Repair: Causes of Valve Failure and Long Term Outcomes |
| Q44896869 | Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency |
| Q61648381 | Bioprosthetic Tricuspid Valve Stenosis in End-Stage Renal Failure |
| Q40270967 | Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors. |
| Q53266113 | Bioprosthetic valve thrombosis: The eyes will not see what the mind does not know. |
| Q89301784 | Bioprosthetic valve thrombosis: What we know and what we need to know |
| Q47897813 | Biplane intraoperative transesophageal echocardiography in congenital heart disease |
| Q61648412 | Bulging Subaortic Septum: An Important Risk Factor for Systolic Anterior Motion After Mitral Valve Repair |
| Q61648669 | Bypass conduit vessel wall biology substantially influences downstream myocardial contractile response to injury from ischemia and reperfusion |
| Q44212437 | C-reactive protein relaxes human vessels in vitro |
| Q47891205 | Calcific constrictive pericarditis: is it still with us? |
| Q61648273 | Carcinoid Heart Disease without Severe Tricuspid Valve Involvement |
| Q35665573 | Carcinoid disease of the heart. Surgical management of ten patients |
| Q53553909 | Carcinoid heart disease and carcinoid syndrome: successful surgical treatment. |
| Q61648569 | Carcinoid heart disease associated with primary ovarian carcinoid tumor |
| Q78299077 | Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling |
| Q61648413 | Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy |
| Q40839850 | Cardiac Myxomas: A 50-Year Experience With Resection and Analysis of Risk Factors for Recurrence |
| Q61648541 | Cardiac Surgery in Kidney and Liver Transplant Recipients |
| Q91007070 | Cardiac amyloidosis in aortic stenosis-icebergs and Archimedes' principle |
| Q88218433 | Cardiac myxoma: Simplifying a "complex" case |
| Q43622806 | Cardiac phaeochromocytoma presenting with severe hypertension and chest pain |
| Q48473763 | Cardiac surgery in patients with body mass index of 50 or greater |
| Q47903933 | Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up |
| Q61648415 | Cardiopulmonary Bypass During Pregnancy |
| Q61648757 | Cardiorespiratory response to exercise after definitive repair of univentricular atrioventricular connection |
| Q61648714 | Cardiorespiratory response to exercise after the Fontan operation: A serial study |
| Q54511418 | Cardiovascular effects of protamine sulfate in man. |
| Q64102689 | Cellular characterization of human epicardial adipose tissue: highly expressed PAPP-A regulates insulin-like growth factor I signaling in human cardiomyocytes |
| Q50861513 | Changes in left ventricular volume and decline in ejection fraction after degenerative mitral valve repair: The math makes sense. |
| Q39629779 | Chronic aortic regurgitation: indications for operation--1988. |
| Q39408944 | Circulating beta-atrial natriuretic factor in congestive heart failure in humans |
| Q38099655 | Circulatory support during crossclamping of the descending thoracic aorta. Evidence of improved organ perfusion |
| Q69777577 | Clamp/repair of traumatic transection of descending aorta |
| Q61648500 | Clinical Outcome After Surgical Correction of Mitral Regurgitation Due to Papillary Muscle Rupture |
| Q61648454 | Clinical Outcome of Asymptomatic Severe Aortic Stenosis With Medical and Surgical Management: Importance of STS Score at Diagnosis |
| Q92381884 | Clinical Outcomes of Surgical Unroofing of Myocardial Bridging in Symptomatic Patients |
| Q35567192 | Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery |
| Q61648684 | Clinical and Operative Characteristics of Patients Randomized to Coronary Artery Bypass Surgery in the Bypass Angioplasty Revascularization Investigation (BARI) |
| Q43959633 | Clinical and hemodynamic evaluation of the 19 mm Björk-Shiley aortic valve prosthesis |
| Q33174394 | Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). |
| Q44605527 | Clinical outcome of mitral regurgitation due to flail leaflet |
| Q47887481 | Clinical predictors and consequences of atrial fibrillation after surgical myectomy for obstructive hypertrophic cardiomyopathy |
| Q92074678 | Clinicopathological, immunophenotypic and genetic studies of mediastinal paragangliomas† |
| Q73930626 | Coarctation of the aorta: collateral flow assessment with phase-contrast MR angiography |
| Q38121360 | Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair |
| Q93177714 | Coexistent bicuspid aortic valve and mitral valve prolapse: epidemiology, phenotypic spectrum, and clinical implications |
| Q45420794 | Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass |
| Q54022703 | Combined operation for lung cancer and cardiac disease. |
| Q49887872 | Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy |
| Q99200132 | Comparative Effectiveness of Mechanical Valves and Homografts in Complex Aortic Endocarditis |
| Q30279022 | Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial). |
| Q54419389 | Comparison of atriopulmonary versus atrioventricular connections for modified Fontan/Kreutzer repair of tricuspid valve atresia. |
| Q73555382 | Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding |
| Q69870122 | Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry |
| Q37282261 | Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis. |
| Q33867516 | Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. |
| Q53619882 | Comparison of early hemodynamic performance of 3 aortic valve bioprostheses. |
| Q61648751 | Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: A coronary artery surgery study registry study |
| Q43796487 | Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy |
| Q92640487 | Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy |
| Q67267466 | Comparison of regional myocardial blood flow and metabolism distal to a critical coronary stenosis in the fibrillating heart during alternate periods of pulsatile and nonpulsatile perfusion |
| Q72187965 | Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience |
| Q72187970 | Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience |
| Q47872580 | Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy |
| Q33162049 | Comparison of surgical septal myectomy to medical therapy alone in patients with hypertrophic cardiomyopathy and syncope. |
| Q61648671 | Comparison of techniques for implantation of aortic valve allografts |
| Q46114695 | Comparisons of the release of vasodilator substances from left and right cardiac chambers of the isolated perfused rabbit heart: implications for intraventricular thrombus formation. |
| Q68859471 | Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators |
| Q73914599 | Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection |
| Q53385452 | Completion pericardiectomy for recurrent constrictive pericarditis: importance of timing of recurrence on late clinical outcome of operation. |
| Q53127885 | Comprehensive Imaging in Women With Organic Mitral Regurgitation: Implications for Clinical Outcome. |
| Q93636519 | Concomitant cardiac and pulmonary operations |
| Q44845677 | Concomitant septal myectomy at the time of aortic valve replacement for severe aortic stenosis |
| Q39300135 | Concomitant surgery for renal neoplasm with pulmonary tumor embolism |
| Q92348944 | Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy |
| Q43891466 | Conduit choice for coronary artery bypass grafting after mediastinal radiation |
| Q37576008 | Congenital coronary anomalies and surgical treatment |
| Q40825543 | Congenital partial and complete absence of the pericardium |
| Q61648594 | Congenital right coronary artery aneurysm causing myocardial infarction, pseudoaneurysm formation, and right atrial compression |
| Q38117352 | Congenitally Corrected Transposition of Great Arteries: Surgical Options for the Failing Right Ventricle and/or Severe Tricuspid Regurgitation |
| Q47897308 | Congestive heart failure after surgical correction of mitral regurgitation. A long-term study |
| Q47865566 | Congestive heart failure complicating aortic regurgitation with medical and surgical management: a prospective study of traditional and quantitative echocardiographic markers |
| Q35546630 | Constrictive pericarditis in 26 patients with histologically normal pericardial thickness |
| Q47701469 | Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy |
| Q38235084 | Constrictive pericarditis--a curable diastolic heart failure |
| Q91615845 | Contemporary Etiologies, Mechanisms, and Surgical Approaches in Pure Native Aortic Regurgitation |
| Q57467973 | Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States |
| Q50061086 | Contemporary Techniques of Pericardiectomy for Pericardial Disease |
| Q72962482 | Control of Ca2+ influx by manipulation of Ca2+ and/or Ca2+ antagonist in cardioplegic arrest |
| Q91692697 | Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy |
| Q72923472 | Cor triatriatum: diagnosis, operative approach, and late results |
| Q61648355 | Coronary Arteriovenous Fistula in a Patient with Aortic Valve Regurgitation |
| Q61648296 | Coronary Artery Fistulae |
| Q61648595 | Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) |
| Q61648672 | Coronary Bypass Surgery with Internal-Thoracic-Artery Grafts — Effects on Survival over a 15-Year Period |
| Q52708006 | Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. A report from the Coronary Artery Surgery Study. |
| Q37779697 | Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved. |
| Q33838662 | Coronary artery bypass in patients with type 2 diabetes: experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. |
| Q45028085 | Coronary artery disease in adult congenital heart disease: outcome after coronary artery bypass grafting |
| Q40404145 | Coronary artery endothelial function after myocardial ischemia and reperfusion |
| Q61648633 | Course guidelines for minimally invasive cardiac surgery |
| Q61648634 | Course guidelines for minimally invasive cardiac surgery |
| Q33881164 | Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience |
| Q67930928 | Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries |
| Q69587773 | Current status of valve replacement in children |
| Q54253972 | Current trends in bilateral internal thoracic artery use for coronary revascularization: Extending benefit to high-risk patients. |
| Q33720207 | Data entry and data accuracy |
| Q42402853 | Debranching of the arch in aortic aneurysms |
| Q61648422 | Deep hypothermic circulatory arrest is not a risk factor for acute kidney injury in thoracic aortic surgery |
| Q68986368 | Definitive operation for pulmonary atresia with intact ventricular septum. Results in twenty patients |
| Q58615337 | Degenerative Mitral Regurgitation After Non-Mitral Cardiac Surgery: MitraClip Versus Surgical Reconstruction |
| Q69387711 | Deoxyribonucleic acid ploidy pattern of cardiac myxomas. Another predictor of biologically unusual myxomas |
| Q72560696 | Detection of intraluminal release of endothelium-derived relaxing factor from human saphenous veins |
| Q104745886 | Determinants of Morbidity and Mortality Associated With Isolated Tricuspid Valve Surgery |
| Q52573029 | Determinants of Reverse Remodeling of the Left Atrium Following Transaortic Myectomy. |
| Q61648502 | Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation |
| Q61648716 | Determinants of survival and recovery of left ventricular function after aortic valve replacement |
| Q44654831 | Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study--CASS. |
| Q67246221 | Development of regional myocardial ischemia distal to a critical coronary stenosis during cardiopulmonary bypass: comparison of the fibrillating vs. the beating nonworking states |
| Q61648800 | Diagnosis and Management of Postoperative Pericardial Effusions and Late Cardiac Tamponade Following Open-Heart Surgery |
| Q47899205 | Diagnostic role of Doppler echocardiography in constrictive pericarditis |
| Q92524154 | Diastolic Blood Pressure and Heart Rate Are Independently Associated With Mortality in Chronic Aortic Regurgitation |
| Q61648425 | Diastolic Dysfunction in Patients Undergoing Cardiac Surgery |
| Q36987798 | Diastolic function and new-onset atrial fibrillation following cardiac surgery. |
| Q74625355 | Differences in heart valve procedures between North American and European centers: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT) |
| Q61648619 | Different effects of protamine on canine coronary microvessel and conductance arteries: Evidence of hyperpolarizing factor release |
| Q73197376 | Different effects of protamine on canine coronary microvessel and conductance arteries: evidence of hyperpolarizing factor release |
| Q89449518 | Dissecting myocardial mechanics in patients with severe aortic stenosis: 2-dimensional vs 3-dimensional-speckle tracking echocardiography |
| Q44018552 | Do differences in early hemodynamic performance of current generation biologic aortic valves predict outcomes 1 year following surgery? |
| Q47992105 | Do pericardial bioprostheses improve outcome of elderly patients undergoing aortic valve replacement? |
| Q58542006 | Does Mitral Valve Calcium In Patients Undergoing Mitral Valve Replacement Portend Worse Survival? |
| Q96029991 | Does Referral Bias Impact Outcomes of Surgery for Degenerative Mitral Valve Disease? |
| Q99726574 | Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy? |
| Q61648427 | Does early surgical intervention improve left ventricular mass regression after mitral valve repair for leaflet prolapse? |
| Q46058039 | Does metabolic syndrome influence bioprosthetic mitral valve degeneration and reoperation rate? |
| Q42402918 | Does only the proximal descending aorta influence aortic dilatation after repair of the aortic dissection? |
| Q61648523 | Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting? |
| Q61648240 | Does septal myectomy reduce risk of sudden cardiac death in patients with hypertrophic cardiomyopathy? |
| Q47402794 | Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy? |
| Q61648460 | Does the dilated ascending aorta in an adult with congenital heart disease require intervention? |
| Q61648382 | Double-Orifice Left Atrioventricular Valve in Patients With Atrioventricular Septal Defects: Surgical Strategies and Outcome |
| Q36193443 | Dysplastic aortic cusp presenting with myocardial ischemia: diagnostic value of transesophageal echocardiography. |
| Q90702150 | Early Outcomes of Cardiac Surgery in Patients with Noonan Syndrome |
| Q50042645 | Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients With Hypertrophic Cardiomyopathy. |
| Q50063993 | Early Prosthetic Valve Dysfunction Due to Bioprosthetic Valve Thrombosis: The Role of Echocardiography |
| Q71807843 | Early Results of a Simplified Method of Mitral Valve Annuloplasty |
| Q38440177 | Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome: a prospective, multicenter, comparative study |
| Q41126557 | Early and Late Outcomes of Surgical Treatment in Carcinoid Heart Disease |
| Q39514252 | Early and late results after isolated coronary artery bypass surgery in 159 patients aged 80 years and older |
| Q61648769 | Early and late results following repair of dissections of the descending thoracic aorta |
| Q69997342 | Early and late results following repair of dissections of the descending thoracic aorta |
| Q70058454 | Early and late results of coronary artery bypass after failed angioplasty. Actuarial analysis of late cardiac events and comparison with initially successful angioplasty |
| Q70063076 | Early and late results of pericardiectomy for constrictive pericarditis |
| Q61648725 | Early and late results of the modified Fontan procedure for doubleinlet left ventricle: The Mayo Clinic experience |
| Q45132370 | Early and late survival after surgical treatment of culture-positive active endocarditis |
| Q44005630 | Early clinical and hemodynamic evaluation of the aortic intact porcine bioprosthesis |
| Q47913151 | Early repair of mechanical complications after acute myocardial infarction |
| Q102323045 | Early septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy |
| Q61648325 | Early structural valve deterioration of the Trifecta aortic valve biological prosthesis: A word of caution |
| Q73994775 | Early surgery for mitral regurgitation: the advantages of youth |
| Q47894845 | Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study. |
| Q37921923 | Early thrombosis risk in patients with biologic valves in the aortic position |
| Q61648326 | Echocardiographic Diagnosis of Constrictive Pericarditis |
| Q47898432 | Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications |
| Q34060140 | Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation |
| Q61648636 | Editorial |
| Q40022533 | Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair: Long-Term Analysis of Competing Outcomes |
| Q44469342 | Effect of arginine vasopressin on the canine epicardial coronary artery: experiments on V1-receptor-mediated production of nitric oxide |
| Q68269776 | Effect of blood conservation efforts in cardiac operations at the Mayo Clinic |
| Q44524045 | Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry |
| Q44212731 | Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. |
| Q40682440 | Effect of potassium cardioplegia on myocardial ischemia and post arrest ventricular function |
| Q37202977 | Effect of the effluent released from the canine internal mammary artery after intraluminal and extraluminal perfusion of acetylcholine and adenosine diphosphate |
| Q45062818 | Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves |
| Q39301207 | Effectiveness of rivaroxaban for thromboprophylaxis of prosthetic heart valves in a porcine heterotopic valve model |
| Q75323967 | Effects of calcium administration during post-ischemic reperfusion on myocardial contractility, stiffness, edema, and ultrastructure |
| Q42668619 | Effects of nitroglycerin on regional myocardial ischemia induced by atrial pacing in dogs |
| Q47869680 | Effects of surgical septal myectomy on left ventricular wall thickness and diastolic filling. |
| Q74218142 | Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts |
| Q52061600 | Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. |
| Q61648253 | Electrical storms in patients with apical aneurysms and hypertrophic cardiomyopathy with midventricular obstruction: A case series |
| Q46162639 | Embolic potential of cardiac tumors and outcome after resection: a case-control study |
| Q96022244 | Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis |
| Q43986581 | Endothelial cell dysfunction after ischemic arrest and reperfusion: a possible mechanism of myocardial injury during reflow |
| Q61648620 | Endothelial regulation of vascular contraction in radial and internal mammary arteries |
| Q61648637 | Endothelial sodding of the permaflow prosthetic coronary artery bypass conduit |
| Q67923179 | Endothelium-dependent contraction and relaxation of the human and canine internal mammary artery: studies on bypass graft vasospasm |
| Q44510032 | Endothelium-dependent relaxation in response to poly-L-arginine in canine coronary arteries: implications about hyperpolarization as a mechanism of vasodilatation |
| Q44468762 | Endothelium-dependent relaxation to poly-L-arginine in canine coronary arteries. |
| Q70595515 | Endothelium-dependent response of human internal mammary artery to hypoxia |
| Q45019917 | Endothelium-dependent vasodilation during acute rejection in dogs |
| Q54110137 | Endothelium-dependent vasodilation in response to Pseudomonas aeruginosa lipopolysaccharide: an in vitro study on canine arteries. |
| Q71835604 | Enlargement of the aortic root or anulus with autogenous pericardial patch during aortic valve replacement. Long-term follow-up |
| Q72775944 | Enteric protein loss after the Fontan operation |
| Q61648295 | Erratum: Constrictive pericarditis—a curable diastolic heart failure |
| Q52485476 | Esophagogastric anastomoses: the value of fibrin glue in preventing leakage. |
| Q61648581 | Evaluation of a novel 2 mm internal diameter stainless steel saphenous vein to coronary artery connector: laboratory studies of on-pump and off-pump revascularization |
| Q38559033 | Event status of the Starr-Edwards aortic valve to 20 years: a benchmark for comparison |
| Q43564840 | Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass |
| Q38080708 | Evidence-based surgical management of acquired tricuspid valve disease |
| Q61648301 | Evolving Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy∗ |
| Q47893275 | Excess mortality due to coronary artery disease after valve surgery. Secular trends in valvular regurgitation and effect of internal mammary artery bypass. |
| Q70032069 | Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle |
| Q69260662 | Exercise tolerance and cardiorespiratory response to exercise before and after the Fontan operation |
| Q72997053 | Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium |
| Q45801690 | Expanding relevance of aortic valve repair-is earlier operation indicated? |
| Q39254847 | Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction |
| Q40100832 | Experience With Pericardiectomy for Constrictive Pericarditis Over Eight Decades. |
| Q61648653 | Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries |
| Q37394759 | Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy. |
| Q33174792 | Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy |
| Q43416650 | Extent of pericardial resection for constrictive pericardiectomy |
| Q61648387 | Extra-anatomic Bypass Graft for Recurrent Aortic Arch Obstruction |
| Q61648302 | Extracorporeal Membrane Oxygenation Support in Postcardiotomy Elderly Patients: The Mayo Clinic Experience |
| Q61648819 | Failure of methylprednisolone to protect myocardial function or prevent myocardial edema following ischemic cardiac arrest |
| Q37254704 | Familial paragangliomas: case report and literature review |
| Q61648790 | Fatal pulmonary artery banding in truncus arteriosus with anomalous origin of circumflex coronary artery from right pulmonary artery |
| Q61648542 | Fate of Bicuspid Aortic Valves in Patients Undergoing Aortic Root Repair or Replacement for Aortic Root Enlargement |
| Q61648429 | Fate of nonreplaced sinuses of Valsalva in bicuspid aortic valve disease |
| Q36123906 | Fifty years of open heart surgery at the Mayo Clinic |
| Q38514255 | Five- to fifteen-year follow-up after Fontan operation |
| Q39437589 | Fixed left ventricular outflow tract obstruction in presumed hypertrophic obstructive cardiomyopathy: implications for therapy |
| Q61648276 | Fixed versus dynamic subaortic stenosis: Hemodynamics and resulting differences in Doppler echocardiography and aortic pressure contour |
| Q69989496 | Flow capacity of the canine internal mammary artery |
| Q47876835 | Fontan conversion: identifying the high-risk patient |
| Q30826605 | Fontan operation in 176 patients with tricuspid atresia. Results and a proposed new index for patient selection |
| Q73248019 | Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery byp |
| Q43922023 | Functional tricuspid regurgitation at the time of mitral valve repair for degenerative leaflet prolapse: the case for a selective approach |
| Q72791910 | Gender differences in left ventricular functional response to aortic valve replacement |
| Q61648543 | Gene Therapy for Vein Graft Disease |
| Q34119443 | Gene therapy for vein graft disease |
| Q45855790 | Gene transfer to coronary artery bypass conduits |
| Q61648461 | Giant Left Atrium Needed Negative Pressure Ventilation |
| Q68142791 | Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass |
| Q61648278 | Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction |
| Q54479901 | Hemodynamic effects of calcium chloride injection following cardiopulmonary bypass: response to bolus injection and continuous infusion. |
| Q52418522 | Hemodynamic performance of small aortic valve bioprostheses: is there a difference? |
| Q35847567 | Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass: a prospective, randomized double-blind trial |
| Q61648582 | Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery |
| Q61648431 | Hepatic Resection for the Carcinoid Syndrome in Patients with Severe Carcinoid Heart Disease: Does Valve Replacement Permit Safe Hepatic Resection? |
| Q77754676 | Hepatoatrial anastomosis and tricuspid valve replacement in Budd-Chiari syndrome 8 |
| Q82093016 | High-frequency ultrasonic waves cause endothelial dysfunction on canine epicardial coronary arteries |
| Q45019916 | Hirudin (desulfated, 54-65) contracts canine coronary arteries: extracellular calcium influx mediates hirudin-induced contractions |
| Q68095173 | Histologic comparison of experimental coronary artery bypass grafts. Similarity of in situ and free internal mammary artery grafts |
| Q61648256 | History of The Journal of Thoracic and Cardiovascular Surgery |
| Q61648484 | Hybrid Approach to Repair of Pulmonary Venous Baffle Obstruction After Atrial Switch Operation |
| Q53793867 | Hybrid alternate approach for complex radiation-induced valvular disease. |
| Q71530762 | Hyperosmolar reperfusion following ischemic cardiac arrest: Critical importance of the timing of mannitol administration on preservation of myocardial structure and function |
| Q61648639 | Hypertrophic Cardiomyopathy with Obstruction: Important Diagnostic Clue Provided by the Direction of the Mitral Regurgitation Jet |
| Q50083266 | Hypertrophic Obstructive Cardiomyopathy: Surgical Myectomy and Septal Ablation |
| Q61648257 | Hypertrophic cardiomyopathy in children |
| Q34616043 | Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy |
| Q39465841 | Hypertrophic obstructive cardiomyopathy: preoperative echocardiographic predictors of outcome after septal myectomy |
| Q41698078 | Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. |
| Q61648641 | Hypomagnesemia Inhibits Nitric Oxide Release From Coronary Endothelium: Protective Role of Magnesium Infusion After Cardiac Operations11This article has been selected for the open discussion forum on the STS Web site: http://www.sts.org/annals |
| Q100745345 | Hyponatremia: an overlooked risk factor associated with adverse outcomes after cardiac surgery |
| Q50526193 | Hypothermic storage with University of Wisconsin solution preserves endothelial and vascular smooth-muscle function. |
| Q61648643 | Hypoxia Increases Vasodilator Release From Internal Mammary Artery and Saphenous Vein Grafts |
| Q41654700 | Identification of persistent myocardial ischemia in patients developing left ventricular dysfunction following aortic valve replacement |
| Q53454541 | Identifying patients at particular risk of injury during repeat sternotomy: analysis of 2555 cardiac reoperations. |
| Q72832972 | Idiopathic pulmonary hilar fibrosis: an unusual cause of pulmonary hypertension |
| Q39486144 | Imaging strategies for vascular rings |
| Q98614894 | Impact of Hematologic Malignancies on Outcome of Cardiac Surgery |
| Q33792405 | Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients |
| Q48658547 | Impact of Left Ventricular Systolic Function on Outcome of Correction of Chronic Severe Aortic Valve Regurgitation: Implications for Timing of Surgical Intervention. |
| Q50168884 | Impact of Medical Therapy on Late Morbidity and Mortality After Aortic Aneurysm Repair for Aortitis. |
| Q57642389 | Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction |
| Q47885369 | Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy |
| Q48509206 | Impact of left ventricular function on immediate and long-term outcomes after pericardiectomy in constrictive pericarditis. |
| Q47893107 | Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications |
| Q51287044 | Impact of prosthesis-patient mismatch on long-term survival in patients with small St Jude Medical mechanical prostheses in the aortic position. |
| Q64948547 | Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction. |
| Q72024274 | Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ischemia: outcome with medical therapy versus revascularization |
| Q43515060 | Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia |
| Q40522143 | Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: a community-based study |
| Q92899223 | Importance of Research in the Training of Thoracic Surgeons |
| Q51324348 | Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). |
| Q87410533 | Important Update for the Readers of Our Article |
| Q71518162 | Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992 |
| Q37090922 | Improved late survival with arterial revascularization |
| Q44229142 | Improved prognosis of thoracic aortic aneurysms: a population-based study |
| Q43744687 | Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry |
| Q42620768 | Improving affordability through innovation in the surgical treatment of mitral valve disease |
| Q90348249 | Improving outcome of valve replacement for carcinoid heart disease |
| Q51687331 | Improving results of open arch replacement. |
| Q61648557 | In vivo detection of encapsulated intracardiac paraganglioma by delayed gadolinium enhancement magnetic resonance imaging. |
| Q46579719 | In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation |
| Q44223556 | Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation |
| Q44646153 | Increased risk of acute kidney injury in patients undergoing tricuspid valve surgery |
| Q61648485 | Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation |
| Q44625235 | Indications for and outcomes of valve replacement for asymptomatic aortic valve stenosis |
| Q36942570 | Indications for surgery in degenerative mitral valve disease |
| Q61648654 | Indications, Effectiveness, and Long-Term Dependency in Permanent Pacing After Cardiac Surgery |
| Q91847519 | Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations |
| Q42547251 | Inferior wall myocardial infarction caused by anomalous right coronary artery |
| Q61648524 | Influence of Preoperative Atrial Fibrillation on Late Results of Mitral Repair: Is Concomitant Ablation Justified? |
| Q70308724 | Influence of antioxidants (mannitol and allopurinol) on oxygen free radical generation during and after cardiopulmonary bypass |
| Q41572337 | Influence of aortitis on late outcomes after repair of ascending aortic aneurysms |
| Q68180365 | Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass |
| Q67538176 | Influence of coronary artery anatomy on survival following resection of left ventricular aneurysms and chronic infarcts |
| Q44535118 | Influence of mitral valve repair versus replacement on the development of late functional tricuspid regurgitation |
| Q51846938 | Influence of propranolol plasma levels on hemodynamics during coronary artery bypass surgery. |
| Q47381958 | Influence of prosthesis size on change in left ventricular mass following aortic valve replacement |
| Q43184769 | Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses. |
| Q69991285 | Initial experience with sequential internal mammary artery bypass grafts to the left anterior descending and left anterior descending diagonal coronary arteries |
| Q51063638 | Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. |
| Q69001824 | Intermediate follow-up and predicted survival after the modified Fontan procedure for tricuspid atresia and double-inlet ventricle |
| Q61648526 | Intermediate-term results of ascending–descending posterior pericardial bypass of complex aortic coarctation |
| Q42453749 | Intracellular calcium transients in human working myocardium as detected with aequorin |
| Q48322866 | Intraoperative direct measurement of left ventricular outflow tract gradients to guide surgical myectomy for hypertrophic cardiomyopathy |
| Q33951562 | Intraoperative echocardiography in valvular heart disease: an evidence-based appraisal. |
| Q47901418 | Intraoperative evaluation of mitral valve regurgitation and repair by transesophageal echocardiography: incidence and significance of systolic anterior motion |
| Q46593353 | Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients |
| Q36981111 | Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases |
| Q33868259 | Intraoperative transesophageal echocardiography: 5-year prospective review of impact on surgical management |
| Q41284123 | Intraoperative two-dimensional Doppler echocardiography. A preliminary study for congenital heart disease. |
| Q43761537 | Intravascular retrieval of broken guide wire from the ascending aorta after percutaneous transluminal coronary angioplasty |
| Q61648242 | Invited Commentary |
| Q61648244 | Invited Commentary |
| Q61648280 | Invited Commentary |
| Q44755567 | Ionic radiocontrast inhibits endothelium-dependent vasodilation of the canine renal artery in vitro: possible mechanism of renal failure following contrast medium infusion |
| Q44726941 | Irrigated bipolar radiofrequency ablation with transmurality feedback for the surgical Cox-Maze procedure |
| Q38470788 | Irrigated radiofrequency ablation with transmurality feedback reliably produces Cox maze lesions in vivo |
| Q46469323 | Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? |
| Q61648571 | Is repair of aortic valve regurgitation a safe alternative to valve replacement? |
| Q61648486 | Is the Anterior Intertrigonal Distance Increased in Patients With Mitral Regurgitation Due to Leaflet Prolapse? |
| Q51682669 | Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? |
| Q43796411 | Is there a role for the left ventricle apical-aortic conduit for acquired aortic stenosis? |
| Q41730728 | Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation. |
| Q102062901 | Is there referral bias in outcomes of septal myectomy for hypertrophic cardiomyopathy? |
| Q47901931 | Ischemia of the interventricular septum. A mechanism of right ventricular failure during mechanical left ventricular assist |
| Q39728451 | Issues concerning the clinical evaluation of new prosthetic valves. |
| Q61648487 | Laparoscopic Transdiaphragmatic Access to the Apex of the Left Ventricle of the Heart |
| Q83713947 | Laparoscopic transdiaphragmatic access to the apex of the left ventricle of the heart |
| Q101131551 | Late Health Status of Patients Undergoing Myectomy for Obstructive Hypertrophic Cardiomyopathy |
| Q61648336 | Late Outcome of Noncoronary Sinus Replacement in Patients With Bicuspid Aortic Valves and Aortopathy |
| Q61648283 | Late durability of decellularized allografts for aortic valve replacement: A word of caution |
| Q61648584 | Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits |
| Q71862843 | Late mediastinal infection and pseudoaneurysm following left ventricular aneurysmectomy: repair utilizing a pectoralis major muscle flap |
| Q61648583 | Late outcome of mitral valve surgery for patients with coronary artery disease |
| Q43433238 | Late outcome of repair of congenital coronary artery fistulas--a word of caution |
| Q44039828 | Late outcomes for surgical repair of supravalvar aortic stenosis |
| Q51541886 | Late outcomes of reintervention on the descending aorta after repair of aortic coarctation. |
| Q33146072 | Late pulmonary valve replacement after repair of tetralogy of Fallot |
| Q70625614 | Late results after Starr-Edwards valve replacement in children |
| Q61648687 | Late results of systemic atrioventricular valve replacement in corrected transposition |
| Q51707274 | Late results of the peel operation for replacement of failing extracardiac conduits. |
| Q44001678 | Late results of valve replacement with the Björk-Shiley valve (1973 to 1982) |
| Q61648436 | Left Atrial Ganglion Ablation as an Adjunct to Atrial Fibrillation Surgery in Valvular Heart Disease |
| Q37364418 | Left Internal Mammary Artery Versus Coronary Stents: Impact on Downstream Coronary Stenoses and Conduit Patency |
| Q61648490 | Left Ventricular Mass Regression After Porcine Versus Bovine Aortic Valve Replacement: A Randomized Comparison |
| Q47365306 | Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve-in-Ring Implantation: A Word of Caution. |
| Q90592792 | Left atrial to left ventricle bypass for mitral valve stenosis |
| Q52683247 | Left ventricular apical aneurysm resection in hypertrophic cardiomyopathy. |
| Q43519832 | Left ventricular dysfunction after mitral valve repair--the fallacy of "normal" preoperative myocardial function |
| Q51156917 | Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status. |
| Q91749511 | Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis |
| Q89747095 | Left ventricular filling pressure and survival following aortic valve replacement for severe aortic stenosis |
| Q69668798 | Left ventricular function in subacute and chronic mitral regurgitation. Effect on function early postoperatively |
| Q47883445 | Left ventricular remodeling after valve replacement in patients with isolated aortic regurgitation |
| Q61648463 | Left ventricular remodeling early after correction of mitral regurgitation: Maintenance of stroke volume with decreased systolic indexes |
| Q50708725 | Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement. |
| Q70990073 | Long-term (5 year) results of coronary bypass surgery in patients 65 years old or older: a report from the Coronary Artery Surgery Study |
| Q28264486 | Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy |
| Q38236422 | Long-term follow-up after pulmonary valve replacement in repaired tetralogy of Fallot. |
| Q45104405 | Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? |
| Q41949337 | Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries |
| Q72791924 | Long-term outcome of surgical repair of ruptured sinus of Valsalva aneurysm |
| Q92668162 | Long-term outcomes of patients undergoing tricuspid valve surgery† |
| Q46250619 | Long-term outcomes of survival and freedom from reoperation on the aortic root or valve after surgery for acute ascending aorta dissection |
| Q43999967 | Long-term results of aortic valve replacement with nonviable homografts. |
| Q61648548 | Long-term results of the Konno procedure for complex left ventricular outflow tract obstruction |
| Q37811313 | Long-term risk of aortic events following aortic valve replacement in patients with bicuspid aortic valves |
| Q61648303 | Low Operative Mortality Achieved With Surgical Septal Myectomy |
| Q44102056 | Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory |
| Q90601011 | Lyme Disease-An Unusual Cause of a Mitral Valve Endocarditis |
| Q37898580 | MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation |
| Q37144309 | Malignant primary cardiac tumors: review of a single institution experience |
| Q94662947 | Management of Coronary Artery Aneurysms at the Time of Surgical Revascularization |
| Q104492561 | Management of Subaortic Left Ventricular Outflow Tract Obstruction after Aortic Valve Replacement |
| Q61648529 | Management of ascending aortic aneurysm and valvular incompetence with external remodeling |
| Q37895749 | Management of cardiac myxoma during pregnancy: a case series and review of the literature |
| Q61648438 | Management of less-than-severe mitral regurgitation: should guidelines recommend earlier surgical intervention?☆ |
| Q37600365 | Management of mild aortic stenosis at the time of coronary artery bypass surgery: should the valve be replaced? |
| Q61648337 | Management of mitral regurgitation in Marfan syndrome: Outcomes of valve repair versus replacement and comparison with myxomatous mitral valve disease |
| Q43617586 | Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary? |
| Q53326170 | Management of severe ischemic cardiomyopathy: left ventricular assist device as destination therapy versus conventional bypass and mitral valve surgery. |
| Q61648493 | Management of the Aortic Root in Adult Patients With Conotruncal Anomalies |
| Q47966006 | Management of tricuspid regurgitation in congenital heart disease: is survival better with valve repair? |
| Q46541008 | Management of zone of apposition in parachute left atrioventricular valve in atrioventricular septal defect |
| Q95653893 | Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2-Mediated COVID-19 |
| Q71519384 | Mass spectrometry and phosphorus-31 nuclear magnetic resonance demonstrate additive myocardial protection by potassium cardioplegia and hypothermia during global ischemia |
| Q94560337 | Mayo clinic practice of cardiology |
| Q38802587 | Mechanical Pulmonary Valve Replacement |
| Q48638018 | Mechanical support of patients with heart failure: What are the future hurdles? |
| Q40399234 | Mechanical vs Biologic Valves: Our Modern Day Conundrum |
| Q61648801 | Mechanism of defective oxygen extraction following global ischemia |
| Q52741113 | Mechanism of elevated left ventricular end-diastolic pressure after ischemic arrest and reperfusion. |
| Q39362863 | Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy |
| Q30409200 | Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). |
| Q61648644 | Mechanisms of hemolysis after mitral valve repair: assessment by serial echocardiography |
| Q46415424 | Mediastinal paragangliomas: the mayo clinic experience |
| Q47880107 | Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets |
| Q52870637 | Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. |
| Q61648530 | Melagatran for thromboprophylaxis after mechanical valve implantation: Results in a heterotopic porcine model |
| Q41600993 | Metabolic and functional effects of progressive degrees of hypothermia during global ischemia |
| Q34970332 | Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients |
| Q51327113 | Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve. |
| Q74776214 | Minimally invasive direct coronary artery bypass--a surgical approach for anomalous right coronary artery from left aortic sinus of Valsalva |
| Q38339810 | Minimally invasive mitral valve surgery: Does it make a difference? |
| Q42459304 | Minimally invasive saphenous vein harvesting: endothelial integrity and early clinical results |
| Q51106566 | Minimally invasive video-assisted surgical closure of atrial septal defects: a safe approach. |
| Q37405655 | Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. |
| Q53551324 | Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series. |
| Q61648464 | Mitral Annular Dynamics in Myxomatous Valve Disease |
| Q61648588 | Mitral Regurgitation |
| Q47383705 | Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures |
| Q47426222 | Mitral Valve Prolapse, Psychoemotional Status, and Quality of Life: Prospective Investigation in the Current Era. |
| Q61648389 | Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis |
| Q47856056 | Mitral and tricuspid annular velocities before and after pericardiectomy in patients with constrictive pericarditis |
| Q61648573 | Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy |
| Q45928584 | Mitral annular growth in children following early mechanical mitral valve replacement. |
| Q39500976 | Mitral regurgitation due to ruptured chordae tendineae in patients with hypertrophic obstructive cardiomyopathy |
| Q70076470 | Mitral regurgitation due to ruptured chordae tendineae. Early and late results of valve repair |
| Q81559202 | Mitral regurgitation surgery in heart failure due to ischemic cardiomyopathy: a 24-year experience |
| Q53409984 | Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. |
| Q41646943 | Mitral regurgitation: a new clinical perspective |
| Q40150828 | Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination. |
| Q45190988 | Mitral valve disease in patients with Marfan syndrome undergoing aortic root replacement |
| Q40497020 | Mitral valve gradient after valve repair of degenerative regurgitation with restrictive annuloplasty |
| Q47901233 | Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients |
| Q38273958 | Mitral valve repair in asymptomatic patients with severe mitral regurgitation: pushing past the tipping point |
| Q61648305 | Mitral valve repair in patients with rheumatic heart disease: What are the limits? |
| Q39434829 | Mitral valve replacement or repair after previous coronary artery bypass grafting. |
| Q36057090 | Mitral valve surgery in non-ischemic cardiomyopathy. |
| Q74776219 | Modern management of prosthetic valve anticoagulation |
| Q33858504 | Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study |
| Q61648259 | Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease† |
| Q61648709 | Multiple Aneurysms and Aortic Dissection: An Unusual Manifestation of Marfan's Syndrome |
| Q61648735 | Multiple aortic aneurysms: The results of surgical management |
| Q68694418 | Multiple aortic aneurysms: the results of surgical management |
| Q38027499 | Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease |
| Q89426707 | Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with percutaneous coronary interventions |
| Q44531017 | Mycobacterium chimaera: The ethical duty to disclose the minimal risk of infection to exposed patients |
| Q52678583 | Myectomy and LA-to-LV Conduit for Severe Calcific Mitral Stenosis and Hypertrophic Cardiomyopathy. |
| Q43481128 | Myocardial ischemia distal to critical coronary stenosis during cardiopulmonary bypass: fibrillating vs beating nonworking heart |
| Q67561111 | Myocardial ischemia during cardiopulmonary bypass. The hazards of ventricular fibrillation in the presence of a critical coronary stenosis |
| Q37912735 | Myocardial revascularization by coronary arterial bypass graft: past, present, and future |
| Q38631014 | Myocardial revascularization for unstable angina pectoris |
| Q102994763 | National Trends in Mechanical Valve Replacement in Patients Aged 50 to 70 Years |
| Q51746248 | Natriuresis during and early after cardiopulmonary bypass: relationship to atrial natriuretic factor, aldosterone, and antidiuretic hormone. |
| Q28261612 | Natriuretic peptide system in human heart failure |
| Q46397825 | Natural History of Echocardiographic and Hemodynamic Changes Following Isolated Pericardiectomy for Constrictive Pericarditis. |
| Q61648284 | Natural history of apical hypertrophic cardiomyopathy and novel surgical treatment |
| Q40831948 | New approaches to prevention and treatment of radial artery graft vasospasm |
| Q66995183 | New method of measuring coronary blood flow and myocardial oxygen consumption with mass spectrometry |
| Q41059421 | New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. |
| Q41433202 | New surgical techniques: implications for the cardiac anesthesiologist: mini-thoracotomy for coronary revascularization without cardiopulmonary bypass. |
| Q44730198 | Nitric oxide and prostacyclin in ultrasonic vasodilatation of the canine internal mammary artery. |
| Q57102481 | Nitric oxide and prostacyclin-dependent pathways involvement on in vitro induced hypothermia |
| Q50539327 | Nitric oxide inhibition attenuates systemic hypotension produced by protamine. |
| Q89481671 | Non-physiologic closing of bi-leaflet mechanical heart prostheses requires a new tri-leaflet valve design |
| Q40241864 | Noninvasive measurement of cardiac output by continuous-wave Doppler echocardiography: initial experience and review of the literature |
| Q104286579 | Nonobstructive Hypertrophic Cardiomyopathy in a Patient with Mitral Prosthesis |
| Q61648690 | Novel technique to bioassay endocardium-derived nitric oxide from the beating heart |
| Q50155357 | Occult liver abscess and foreign body perforation of the bowel |
| Q51007750 | Off-pump strategy in high-risk coronary artery bypass reoperations. |
| Q38473754 | On-pump coronary artery bypass graft operation: Is one crossclamp application better than two? |
| Q36459154 | On-pump versus off-pump coronary artery bypass graft surgery among patients with type 2 diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. |
| Q93099939 | One Hundred and Counting: Dr Dwight C. McGoon's Enduring Legacy |
| Q72919248 | One-hour exposure to University of Wisconsin solution does not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries |
| Q38938996 | Open Aortic Arch Reconstruction After Coronary Artery Bypass Surgery: Worth the Effort? |
| Q40443363 | Open Surgical Repair Remains the Gold Standard for Treating Aortic Arch Pathology. |
| Q42678704 | Open aortic arch reconstruction after previous cardiac surgery: outcomes of 168 consecutive operations. |
| Q91402165 | Open hemiarch versus clamped ascending aorta replacement for aortopathy during initial bicuspid aortic valve replacement |
| Q61648604 | Open-Heart Endocardial Radiofrequency Ablation: An Alternative to Incisions in Maze Surgery |
| Q43753733 | Operation for anorexigen-associated valvular heart disease |
| Q61648710 | Operation for ventricular tachyarrhythmias: Refining current treatment strategies |
| Q67591329 | Operative management of penetrating vascular injuries of the thoracic outlet |
| Q51558466 | Operative risk of reoperative aortic valve replacement. |
| Q37532837 | Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis. |
| Q61648306 | Optimal Surgical Ablation of Atrial Tachyarrhythmias During Correction of Ebstein Anomaly |
| Q47570708 | Origins of Cardiovascular Surgery at the Mayo Clinic |
| Q47895905 | Outcome after surgery for mitral regurgitation. Determinants of postoperative morbidity and mortality |
| Q61648439 | Outcome of Caval Division Techniques for Partial Anomalous Pulmonary Venous Connections to the Superior Vena Cava |
| Q61648361 | Outcome of Septal Myectomy in Patients With Fabry's Disease |
| Q52939159 | Outcome of Surgical Repair of Pulmonary Artery Aneurysms: A Single-Center Experience With 38 Patients. |
| Q46509517 | Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy |
| Q72758587 | Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty? |
| Q44761657 | Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting: renal function and mortality after 3.8 years |
| Q61648692 | Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction |
| Q44253188 | Outcome of repair of myocardial bridging at the time of septal myectomy |
| Q46327485 | Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults |
| Q50155724 | Outcome of tricuspid valve surgery in the presence of permanent pacemaker |
| Q61648625 | Outcome of valve repair and the cox maze procedure for mitral regurgitation and associated atrial fibrillation |
| Q47885248 | Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function |
| Q100736266 | Outcomes and risk factors of late failure of valve-sparing aortic root replacement |
| Q92204398 | Outcomes in Chronic Hemodynamically Significant Aortic Regurgitation and Limitations of Current Guidelines |
| Q92022773 | Outcomes of Bioprosthetic Valves in the Pulmonary Position in Adults With Congenital Heart Disease |
| Q38945540 | Outcomes of Warfarin Therapy for Bioprosthetic Valve Thrombosis of Surgically Implanted Valves: A Prospective Study |
| Q53086648 | Outcomes of ring versus suture annuloplasty for tricuspid valve repair in patients undergoing mitral valve surgery. |
| Q50065095 | Outcomes of surgery for infective endocarditis: a single-centre experience of 801 patients |
| Q42278834 | Outcomes of surgery in the treatment of isolated nonnative mitral valve infective endocarditis |
| Q48157663 | Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era. |
| Q38212543 | Outcomes of surgical aortic valve replacement: the benchmark for percutaneous therapies |
| Q39256006 | Outcomes of surgical repair of double-chambered right ventricle |
| Q99209219 | Outcomes of tricuspid valve operation at the time of pericardiectomy for constrictive pericarditis |
| Q101410896 | Outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation |
| Q69638524 | Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation |
| Q72758618 | Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries |
| Q47918319 | Papillary muscle rupture complicating acute myocardial infarction: analysis of 17 patients |
| Q61648598 | Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT |
| Q41120534 | Partial anomalous pulmonary venous return with intact atrial septum: report of four cases |
| Q72791880 | Patency of internal thoracic artery grafts: comparison of right versus left and importance of vessel grafted |
| Q74629929 | Patent foramen ovale transcatheter closure device thrombosis |
| Q30234828 | Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific? |
| Q58574707 | Patient Experience After Cardiac Surgery: Identifying Areas for Improvement |
| Q44105438 | Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch |
| Q61648391 | Percutaneous Approaches to Valvular Heart Disease After Previous Cardiac Surgery |
| Q61648786 | Percutaneous transluminal coronary angioplasty (PTCA) in the elderly patient: Experience in the national heart, lung, and blood institute PTCA registry |
| Q42098430 | Percutaneous transluminal coronary angioplasty and the changing indications for coronary artery bypass grafting for single-vessel coronary artery disease |
| Q67277454 | Percutaneous transluminal coronary angioplasty versus coronary artery bypass. Isn't it time for a randomized trial? |
| Q37681823 | Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management |
| Q39003169 | Pericardiectomy After Previous Bypass Grafting: Analyzing Risk and Effectiveness in this Rare Clinical Entity |
| Q61648494 | Pericardiectomy for Pericarditis in the Pediatric Population |
| Q36523436 | Pericardiectomy vs medical management in patients with relapsing pericarditis |
| Q90668790 | Pericardiotomy Enhances Left Ventricular Diastolic Reserve With Volume Loading in Humans |
| Q44249992 | Pharmacological studies on internal mammary artery bypass grafts. Action of endogenous and exogenous vasodilators and vasoconstrictors. |
| Q69864161 | Plasma levels of beta-blocking drugs prior to coronary artery bypass surgery |
| Q61648605 | Platelet glass bead retention predicts bleeding after cardiac surgery |
| Q61648646 | Policy Statement: Minimally Invasive Coronary Artery Bypass Surgery |
| Q61648645 | Policy statement: Minimally invasive coronary artery bypass surgery |
| Q45721945 | Population-based study of the use of cardiac stress imaging and referral for coronary angiography and repeated revascularization after coronary artery bypass graft surgery |
| Q51599876 | Posterior Leaflet Detachment, Augmentation, and Reconstruction for Treatment of Functional Mitral Valve Regurgitation. |
| Q61648612 | Posterior pericardial approach for ascending aorta-to-descending aorta bypass through a median sternotomy |
| Q74542003 | Posterior pericardial ascending-to-descending aortic bypass: an alternative surgical approach for complex coarctation of the aorta |
| Q41458681 | Potassium-induced cardioplegia during normothermic cardiac arrest. Morphologic study of the effect of varying concentrations of potassium on myocardial anoxic injury |
| Q41737607 | Predictors of Survival and Modes of Failure After Mitroflow Aortic Valve Replacement in 1,003 Adults |
| Q77296595 | Predictors of early- and late-onset supraventricular tachyarrhythmias after Fontan operation |
| Q72683645 | Preoperative diagnosis of coronary artery anatomy in dextrotransposition of the great arteries |
| Q53427728 | Preoperative factors associated with adverse outcome after tricuspid valve replacement. |
| Q90808073 | Preoperative left atrial volume index is associated with postoperative outcomes in mitral valve repair for chronic mitral regurgitation |
| Q61648313 | Preservation of left ventricular function after degenerative mitral valve repair: Refocusing on timing, techniques, and teaching |
| Q51604934 | Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study. |
| Q58975283 | Prevention Conference VI: Diabetes and Cardiovascular Disease |
| Q61648263 | Previously Unreported in Women Galactosidase Alpha Pro409Ser Variant Is Associated With Fabry Disease |
| Q35920412 | Primary cardiac angiosarcoma: a clinicopathologic study of six cases |
| Q44546166 | Production of endothelium-derived contracting factor is enhanced after coronary reperfusion |
| Q61648559 | Prognosis of Carcinoid Heart Disease |
| Q68894251 | Prognostic factors and surgical treatment of partial atrioventricular canal |
| Q51932890 | Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery? |
| Q96232082 | Prognostic importance of mitral e' velocity in constrictive pericarditis |
| Q45226023 | Prolonged exposure of canine coronary arteries to a nitric oxide donor desensitizes soluble guanylate cyclase |
| Q61648695 | Protamine induces endothelium-dependent vasodilatation of the pulmonary artery |
| Q43805963 | Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization |
| Q44992873 | Protective effect of N-acetylcysteine against oxygen radical-mediated coronary artery injury |
| Q61648680 | Protein-losing enteropathy after the Fontan operation |
| Q38666982 | Prothrombin Complex Concentrates in Pediatric Cardiac Surgery: The Current State and the Future |
| Q47990974 | Psycho-emotional manifestations of valvular heart diseases: prospective assessment in mitral regurgitation. |
| Q47755153 | Psychoemotional and quality of life response to mitral operations in patients with mitral regurgitation: a prospective study. |
| Q51467447 | Pulmonary Valve Intimal Sarcoma. |
| Q47397220 | Pulmonary artery size and clinical outcome after the modified Fontan operation |
| Q50926217 | Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy. |
| Q43003101 | Quadruple valve replacement in patients with carcinoid heart disease |
| Q93116233 | Quality of Life of Patients With Marfan Syndrome After Valve-Sparing or Valve-Replacement Operations |
| Q39648202 | Quality of life after early mitral valve repair using conventional and robotic approaches |
| Q47878287 | Quantitative determinants of the outcome of asymptomatic mitral regurgitation |
| Q42930001 | RIFLE is not RIFLE: on the comparability of results |
| Q39660298 | Randomized trials in coronary artery bypass surgery |
| Q45884501 | Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits |
| Q44188114 | Recombinant gene transfer of endothelial nitric oxide synthase augments coronary artery relaxations during hypoxia. |
| Q91466932 | Recommendations for Perioperative Management in Patients With Absent Right Superior Vena Cava |
| Q61648496 | Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse |
| Q61648549 | Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? |
| Q70367809 | Reduced oxygen consumption with effective left ventricular venting during postischemic reperfusion |
| Q61648804 | Reduced oxygen extraction during reperfusion: A consequence of global ischemic arrest |
| Q92539566 | Regional and Temporal Trends in the Outcomes of Repairs for Acute Type A Aortic Dissections |
| Q43664282 | Regional ischemia distal to a critical coronary stenosis during prolonged fibrillation--improvement with pulsatile perfusion |
| Q47405767 | Regression in left ventricular mass after aortic valve replacement for chronic aortic regurgitation is unrelated to prosthetic valve size |
| Q54275701 | Regulation of pulmonary resistance during cardiopulmonary preservation |
| Q61648441 | Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy |
| Q40961196 | Renal artery stenosis following transplantation: etiology, diagnosis, and prevention |
| Q43717110 | Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. |
| Q47994957 | Reoperating after endovascular therapy: A future challenge of cardiovascular surgery. |
| Q61648366 | Reoperation After Arterial Switch: A 27-Year Experience |
| Q61648367 | Reoperation Following Mitral Valve Repair |
| Q61648681 | Reoperation after valve repair for mitral regurgitation: Early and intermediate results |
| Q39066769 | Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures |
| Q61648395 | Reoperation for Prosthetic Mitral Valve Endocarditis |
| Q51043495 | Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation. |
| Q61648658 | Reoperation for hemolytic, anaemia complicating mitral valve repair |
| Q47429484 | Reoperation for mitral paravalvular leak: a single-centre experience with 200 patients. |
| Q70595514 | Reoperation for obstructed pulmonary ventricle-pulmonary artery conduits. Early and late results |
| Q71047179 | Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients |
| Q61648498 | Reoperations After Initial Repair of Complete Atrioventricular Septal Defect |
| Q51569429 | Reoperations after repair of partial atrioventricular septal defect: a 45-year single-center experience. |
| Q61648398 | Reoperations for Mitral Valve Disease: Surgical Approaches and Techniques |
| Q38086650 | Reoperative multivalve surgery in adult congenital heart disease |
| Q98782251 | Repair of Partial Atrioventricular Septal Defects in Adults: A Single Center Experience |
| Q38122762 | Repair of acute inferior wall myocardial infarction-related basal ventricular septal defect: transatrial versus transventricular approach |
| Q61648613 | Repair of anterior leaflet mitral valve prolapse: chordal replacement versus chordal shortening |
| Q69760198 | Repair of ascending aortic dissection. Influence of associated aortic valve insufficiency on early and late results |
| Q61648469 | Repair of the bicuspid aortic valve: A viable alternative to replacement with a bioprosthesis |
| Q52585570 | Repair of tricuspid valve insufficiency in patients undergoing double (aortic and mitral) valve replacement. Perioperative mortality and long-term (1 to 20 years) follow-up in 109 patients. |
| Q41499925 | Repair of type B interruption of the aortic arch in a three day old infant using microporous expanded polytetrafluoroethylene arterial prosthesis |
| Q93116189 | Repeat Coronary Bypass Surgery or Percutaneous Coronary Intervention After Previous Surgical Revascularization |
| Q91147267 | Repeat aortic valve replacement for failing aortic root homograft |
| Q38186175 | Repeat sternotomy for surgical aortic valve replacement in octogenarian patients with aortic valve stenosis and previous coronary artery bypass graft operation: what is the operative risk? |
| Q44740117 | Replacement of obstructed extracardiac conduits with autogenous tissue reconstructions. |
| Q49293235 | Replacement of obstructed right ventricular-pulmonary arterial valved conduits with nonvalved conduits in children |
| Q53405343 | Replacement of the infected composite aortic root prosthesis. |
| Q61648265 | Reply |
| Q91354106 | Reply |
| Q87897415 | Reply to "Is the cause of death in hypertrophic cardiomyopathy low pressure gradient in left ventricular outflow?" |
| Q61648446 | Reply to the Editor |
| Q61648510 | Reply to the Editor |
| Q61648531 | Reply to the Editor |
| Q61648532 | Reply to the Editor |
| Q61648509 | Reply to the Editor: |
| Q53324513 | Reply: To PMID 24655468. |
| Q54508773 | Resection of multiple recurrent cardiac myxomas in an adult man with Carney's complex. |
| Q61648342 | Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy—mechanisms of obstruction and outcomes of reoperation |
| Q61648247 | Response by Nguyen et al to Letter Regarding Article, “Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients with Hypertrophic Cardiomyopathy” |
| Q54676731 | Response to Kaneko et al. |
| Q61648511 | Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery |
| Q61648793 | Results of Reoperation for Periprosthetic Leakage |
| Q45008863 | Results of allograft aortic valve replacement for complex endocarditis |
| Q61648699 | Results of an autologous tissue reconstruction for replacement of obstructed extracardiac conduits |
| Q61648736 | Results of homograft aortic valve replacement for active endocarditis |
| Q44531459 | Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation |
| Q43597272 | Results of mitral valve annuloplasty with a standard-sized posterior band: is measuring important? |
| Q33167729 | Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age. |
| Q70293383 | Results of surgical treatment of ascending aortic dissections occurring late after cardiac operation |
| Q93576352 | Results of the modified Fontan operation for congenital heart lesions in patients without preoperative sinus rhythm |
| Q44798842 | Results of the modified Fontan operation in adults |
| Q61648782 | Results of triple valve replacement in 91 patients: perioperative mortality and long-term follow-up |
| Q93084386 | Right Atrial/Pulmonary Arterial Wedge Pressure Ratio in Primary and Mixed Constrictive Pericarditis |
| Q61648550 | Right-Sided Maze Procedure for Atrial Tachyarrhythmias in Congenital Heart Disease |
| Q38253262 | Risk assessment methods for cardiac surgery and intervention |
| Q45731719 | Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease |
| Q90335322 | Risk factors and progression of systolic anterior motion after mitral valve repair |
| Q91692715 | Risk of conventional cardiac surgery among patients with severe left ventricular dysfunction in the era of mechanical circulatory support |
| Q37921922 | Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome |
| Q35820755 | Risk of repeat mitral valve replacement for failed mitral valve prostheses |
| Q61648703 | Risk of thromboembolism with the aortic Carpentier-Edwards bioprosthesis |
| Q42640980 | Robot-assisted aortic valve replacement using a novel sutureless bovine pericardial prosthesis: proof of concept as an alternative to percutaneous implantation |
| Q35671837 | Robotic mitral valve repair for all categories of leaflet prolapse: improving patient appeal and advancing standard of care. |
| Q42616057 | Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: establishing the benchmark against which percutaneous interventions should be judged |
| Q61648576 | Role of Intraoperative Transesophageal Echocardiography in Patients Having Coronary Artery Bypass Graft Surgery |
| Q51213335 | Ross Procedure for Aortic Valve Replacement in Young Adults: Preferred Procedure or "Double, Double Toil and Trouble"? |
| Q40714227 | Routine use of autotransfusion following cardiac surgery: experience in 700 patients |
| Q51595993 | Safety and biocompatibility of the Myosplint system--a passive implantable device that alters ventricular geometry for the treatment of heart failure. |
| Q61648470 | Safety and durability of mitral valve repair for anterior leaflet perforation |
| Q38679386 | Safety of Noncardiac Surgery in Patients With Hypertrophic Obstructive Cardiomyopathy at a Tertiary Care Center |
| Q53423134 | Safety of same-day coronary angiography in patients undergoing elective aortic valve replacement. |
| Q47871620 | Safety of same-day coronary angiography in patients undergoing elective valvular heart surgery |
| Q88083941 | Seeing Is Not Always Believing: Another Dimension of Functional Mitral Regurgitation |
| Q61648368 | Selection of Aortic Valve Prostheses: Contemporary Reappraisal of Mechanical Versus Biologic Valve Substitutes |
| Q48292206 | Selective convective brain cooling during hypothermic cardiopulmonary bypass in dogs |
| Q48448848 | Selective convective brain cooling during normothermic cardiopulmonary bypass in dogs |
| Q61648536 | Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy |
| Q61648577 | Septal Myectomy Results in Regression of Left Ventricular Hypertrophy in Patients With Hypertrophic Obstructive Cardiomyopathy |
| Q90080108 | Septal Myectomy and Concomitant Coronary Artery Bypass Grafting for Patients With Hypertrophic Cardiomyopathy and Coronary Artery Disease |
| Q90902147 | Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery |
| Q96618076 | Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease |
| Q71077153 | Septal artery revascularization |
| Q61648316 | Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy? |
| Q37021688 | Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy |
| Q43269274 | Septal myectomy for obstructive hypertrophic cardiomyopathy: the gold standard |
| Q61648285 | Septal myectomy for patients with hypertrophic cardiomyopathy: A new paradigm |
| Q61648346 | Septal reduction therapies in hypertrophic cardiomyopathy: comparison of surgical septal myectomy and alcohol septal ablation |
| Q43981933 | Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients |
| Q44487770 | Severe tricuspid regurgitation after mitral valve repair: diagnosis by intraoperative transesophageal echocardiography |
| Q40474694 | Severe tricuspid stenosis: an unusual and unique cause. |
| Q46292700 | Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine |
| Q37808828 | Should the proximal arch be routinely replaced in patients with bicuspid aortic valve disease and ascending aortic aneurysm? |
| Q70242624 | Simplified method of heterotopic cardiac transplantation for left ventricular assist |
| Q45712866 | Simulation-based postcardiotomy extracorporeal membrane oxygenation crisis training for thoracic surgery residents |
| Q61648266 | Single coronary artery arising from the right aortic sinus with dual LAD supply from separate branches |
| Q40881988 | Single versus bilateral internal mammary artery grafts: 10-year outcome analysis |
| Q61648401 | Single-patch, 2-patch, and caval division techniques for repair of partial anomalous pulmonary venous connections: Does it matter? |
| Q28273174 | Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients |
| Q61648471 | Spectrum and Outcome of Reoperations After the Ross Procedure |
| Q50124314 | Spectrum of Aortic Disease in the Giant Cell Arteritis Population. |
| Q74438183 | Spectrum of reoperations after repair of aortic coarctation: importance of an individualized approach because of coexistent cardiovascular disease |
| Q37731974 | Staged balloon aortic valvuloplasty before standard aortic valve replacement in selected patients with severe aortic valve stenosis |
| Q39543542 | Staged surgical repair of pulmonary atresia, ventricular septal defect, and hypoplastic, confluent pulmonary arteries. |
| Q43572891 | Stroke in coronary artery bypass graft surgery: an analysis of the CASS experience. The participants in the Coronary Artery Surgery Study |
| Q51759641 | Superiority of cut-and-sew technique for the Cox maze procedure: comparison with radiofrequency ablation. |
| Q41130364 | Superoxide anion mediates the endothelium-dependent contractions to serotonin by regenerated endothelium |
| Q61648777 | Superoxide generation during cardiopulmonary bypass: Is there a role for vitamin E? |
| Q38124875 | Supravalvar aortic stenosis: current surgical approaches and outcomes |
| Q39487847 | Supravalvular aortic stenosis. Long-term results of surgical treatment. |
| Q35864533 | Surgery for aneurysms of the aortic root: a 30-year experience. |
| Q39202702 | Surgery for biventricular obstruction in hypertrophic cardiomyopathy in children and young adults: technique and outcomes†. |
| Q33916509 | Surgery for cardiac myxomas |
| Q39193381 | Surgery for hypertrophic cardiomyopathy. |
| Q38034679 | Surgery for pericardial disease |
| Q71423852 | Surgery for tricuspid regurgitation late after mitral valve replacement |
| Q36915921 | Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience |
| Q61648318 | Surgical Ablation of Atrial Fibrillation — When, Why, and How? |
| Q61648405 | Surgical Management of Atrial Fibrillation in Redo Cardiac Operations |
| Q61648473 | Surgical Management of Mitral Insufficiency |
| Q61648474 | Surgical Management of Mitral Stenosis |
| Q93190249 | Surgical Myectomy: Subaortic, Midventricular, and Apical |
| Q61648537 | Surgical Ostioplasty for Isolated Left Main Stenosis |
| Q61648371 | Surgical Treatment of Atrial Fibrillation |
| Q61648515 | Surgical Treatment of Atrial Fibrillation |
| Q53294587 | Surgical ablation for atrial fibrillation for two decades: are the results of new techniques equivalent to the Cox maze III procedure? |
| Q47873989 | Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements |
| Q61648476 | Surgical excision of right ventricular carcinoid tumor in a symptomatic patient without carcinoid valve disease |
| Q33157720 | Surgical management of anomalous aortic origin of a coronary artery |
| Q61648514 | Surgical management of ascending aortic aneurysm due to non-infectious aortitis |
| Q82504872 | Surgical management of congenital coronary arterial anomalies in adults |
| Q43603001 | Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course |
| Q46802833 | Surgical management of hypertrophic cardiomyopathy in 2007: what is new? |
| Q43745333 | Surgical management of left-sided carcinoid heart disease. |
| Q37176455 | Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. |
| Q71445189 | Surgical management of patients with the Marfan syndrome and dilatation of the ascending aorta |
| Q49122655 | Surgical management of the aortic root in patients with Marfan syndrome. |
| Q36521268 | Surgical management of valvular heart disease 2004. |
| Q48505327 | Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass |
| Q39215697 | Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy |
| Q57117987 | Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort |
| Q73195680 | Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events |
| Q77624091 | Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years |
| Q38196080 | Surgical repair of cor triatriatum sinister: the Mayo Clinic 50-year experience |
| Q39335763 | Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy |
| Q91524906 | Surgical septal myectomy for relief of dynamic obstruction in Anderson-Fabry Disease |
| Q48924992 | Surgical strategies for anomalous origin of coronary artery from pulmonary artery in adults |
| Q45748932 | Surgical strategy for atrioventricular septal defect and tetralogy of Fallot or double-outlet right ventricle |
| Q41698073 | Surgical treatment for hypertrophic cardiomyopathy: a historical perspective |
| Q46458357 | Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis |
| Q36293706 | Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. |
| Q69428953 | Surgical treatment of complex congenital heart disease with modified Fontan procedure |
| Q39490094 | Surgical treatment of discrete and tunnel subaortic stenosis. Late survival and risk of reoperation |
| Q53974690 | Surgical treatment of double-orifice mitral valve in atrioventricular canal defects. Experience in 25 patients. |
| Q38101967 | Surgical treatment of hypertrophic cardiomyopathy |
| Q38199801 | Surgical treatment of hypertrophic cardiomyopathy |
| Q53489375 | Surgical treatment of saphenous vein graft aneurysms after coronary artery revascularization. |
| Q73324679 | Surgical treatment of valvular heart disease in patients with acromegaly |
| Q39490042 | Surgical treatment of vascular rings: the Mayo Clinic experience |
| Q33164529 | Surgical unroofing of anomalous aortic origin of a coronary artery: a single-center experience |
| Q51503006 | Surgically Constructed Double-Outlet Right Ventricle. |
| Q93056285 | Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality? |
| Q91958870 | Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy |
| Q51141746 | Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. |
| Q43481489 | Survival after resection of primary cardiac tumors: a 48-year experience |
| Q43577207 | Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. |
| Q83509797 | Survival and reoperation risk following bicuspid aortic valve-sparing root replacement |
| Q53622133 | Suture technique does not affect hemodynamic performance of the small supra-annular Trifecta bioprosthesis. |
| Q61648248 | Sutureless Prostheses for Aortic Valve Replacement |
| Q36697176 | Systolic anterior motion after mitral valve repair: is surgical intervention necessary? |
| Q36943410 | TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves |
| Q38311606 | Technical modifications in the repair of acute ischemic posterior ventricular septal defect without ventriculotomy |
| Q51493191 | Temperature and duration of cardiopulmonary bypass influence transfusion requirements. |
| Q44012208 | Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success? |
| Q61648629 | The Allen test |
| Q38417049 | The American Association for Thoracic Surgery Consensus Guidelines: Reasons and purpose |
| Q61648249 | The Brockenbrough-Braunwald-Morrow sign |
| Q61648554 | The Effect of Adjuvant Perfusion Techniques on the Incidence of Paraplegia After Repair of Traumatic Thoracic Aortic Transections |
| Q47555644 | The First Operation for Apical Hypertrophic Cardiomyopathy-Dr Dwight McGoon, 1972. |
| Q61648803 | The Harmful Effects of Ventricular Distention during Postischemic Reperfusion |
| Q61648797 | The Hemodynamic Response to Dopamine and Nitroprusside Following Right Atrium–Pulmonary Artery Bypass (Fontan Procedure) |
| Q103036553 | The Man Behind the Clagett Procedure: Dr. Oscar Theron "Jim" Clagett |
| Q61648650 | The Relation between the Platelet-activated Clotting Test (HemoSTATUS) and Blood Loss after Cardiopulmonary Bypass |
| Q51265439 | The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. |
| Q98774886 | The Surgeon's View of the Left Ventricular Outflow Tract in Congenital Heart Surgery |
| Q77636345 | The advantage of repair of mitral valve in acute endocarditis |
| Q33155934 | The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis |
| Q61648286 | The cardiac surgeon as electrophysiologist |
| Q43037810 | The case for an aggressive surgical approach to papillary muscle rupture following myocardial infarction: "From paradise lost to paradise regained". |
| Q35948306 | The case for surgery in obstructive hypertrophic cardiomyopathy. |
| Q61648811 | The effect of aspirin and dipyridamole on the patency of allograft veins |
| Q61648539 | The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation |
| Q53382917 | The effect of postoperative medical treatment on left ventricular mass regression after aortic valve replacement. |
| Q30408054 | The expanding role of mitral valve repair in triple valve operations: contemporary North American outcomes in 8,021 patients |
| Q42795387 | The increasing use of mechanical pulmonary valve replacement over a 40-year period |
| Q69509544 | The influence of surgery on the natural history of angiographically documented left ventricular aneurysm: the Coronary Artery Surgery Study |
| Q38516426 | The modified Fontan operation for children less than 4 years old. |
| Q40542158 | The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution |
| Q61648591 | The modified fontan procedure: early and late results in 132 adult patients |
| Q39559880 | The morbidity and mortality of reoperation for coronary artery disease and analysis of late results with use of actuarial estimate of event-free interval. |
| Q33167076 | The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years |
| Q51043803 | The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. |
| Q61648704 | The risk of stroke in the early postoperative period following mitral valve replacement |
| Q35087384 | The role of PCI and CABG in the management of coronary artery disease in patients with diabetes |
| Q40789493 | The role of gene therapy for intimal hyperplasia of bypass grafts |
| Q54345287 | The role of neural and vasoactive mediators in the regulation of the pulmonary circulation during cardiopulmonary preservation. |
| Q40442841 | The role of the surgical maze procedure |
| Q28307686 | The significance of multiple, recurrent, and "complex" cardiac myxomas |
| Q51919500 | The successful application of simulation-based training in thoracic surgery residency. |
| Q51312322 | The surgical treatment of concomitant atrial arrhythmias during redo cardiac operations. |
| Q72383248 | Therapeutic implications of intraoperative pressure measurements after the Fontan operation |
| Q44523228 | Third and fourth operations for myocardial ischemia: short-term results and long-term survival |
| Q40475966 | Thoracic aorta false aneurysm: what surgical strategy should be recommended? |
| Q34266837 | Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation |
| Q51613847 | Thoracoscopic versus open mitral valve repair: a propensity score analysis of early outcomes. |
| Q92414325 | Thrombin Generation and Antithrombin Activity in Infants Undergoing Cardiopulmonary Bypass-An Exploratory Study |
| Q28304518 | Thromboembolic splenic infarction |
| Q61648749 | Thrombogenicity of canine free internal mammary artery autografts |
| Q40994353 | Thrombolytic therapy for obstruction of mechanical prosthetic valves |
| Q44825731 | Thrombotic obstruction of disc valves: clinical recognition and surgical management |
| Q39857218 | Thrombotic occlusion of a prosthetic heart valve: diagnosis and management |
| Q44407770 | Time course and extent of recovery of endothelium-dependent contractions and relaxations after direct arterial injury |
| Q68822257 | Time to first new myocardial infarction in patients with mild angina and three-vessel disease comparing medicine and early surgery: a CASS registry study of survival. Coronary Artery Surgery Study |
| Q68091126 | Time to first new myocardial infarction in patients with severe angina and three-vessel disease comparing medical and early surgical therapy: a CASS registry study of survival |
| Q51192063 | Time-related risk of the St. Jude Silzone heart valve. |
| Q61648409 | Transaortic Extended Septal Myectomy for Hypertrophic Cardiomyopathy |
| Q85607214 | Transapical Myectomy for Septal Hypertrophy Not Accessible Through the Aortic Root |
| Q98282802 | Transapical Septal Myectomy for Hypertrophic Cardiomyopathy with Midventricular Obstruction |
| Q39247274 | Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy |
| Q49864674 | Transapical approach for myectomy in hypertrophic cardiomyopathy. |
| Q33162964 | Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy. |
| Q61648349 | Transapical myectomy for severe mid-ventricular obstructive hypertrophic cardiomyopathy: |
| Q56676547 | Transcatheter Aortic-Valve Implantation — At What Price? |
| Q87683794 | Transcatheter Mitral Valve Plication: Innovative Approach for Relief of LVOT Obstruction in High-Risk HCM Patients |
| Q92040448 | Transcatheter Mitral-Valve Repair in Patients with Heart Failure |
| Q91760360 | Transcatheter Valve-in-Valve Vs Surgical Replacement of Failing Stented Aortic Biological Valves |
| Q45069358 | Transcatheter and Surgical Management of Mitral Paravalvular Leak: Long-Term Outcomes. |
| Q38164194 | Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: summary assessment of the California Technology Assessment Forum |
| Q35635040 | Transient constrictive pericarditis: causes and natural history. |
| Q33666475 | Transmyocardial and percutaneous myocardial revascularization: current and future role in the treatment of coronary artery disease |
| Q72823483 | Traumatic tricuspid valve insufficiency. Experience in thirteen patients |
| Q38610491 | Treatment of coronary artery disease |
| Q27027846 | Treatment of obstructive thrombosed prosthetic heart valve |
| Q61648794 | Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole |
| Q61648516 | Tricuspid Regurgitation in Patients Undergoing Pericardiectomy for Constrictive Pericarditis |
| Q61648517 | Tricuspid Valvectomy to Facilitate Repair of Postinfarction Ventricular Septal Defect |
| Q94591274 | Tricuspid valve regurgitation in patients undergoing pericardiectomy for constrictive pericarditis |
| Q78429413 | Two generations of the St. Jude Medical ATG coronary connector systems for coronary artery anastomoses in coronary artery bypass grafting |
| Q45911475 | Type A aortic dissection in patients with bicuspid aortic valves: clinical and pathological comparison with tricuspid aortic valves. |
| Q45055694 | Ultrasonic aortic valve decalcification: serial Doppler echocardiographic follow-up |
| Q36085450 | Understanding Differences in Administrative and Audited Patient Data in Cardiac Surgery: Comparison of the University HealthSystem Consortium and Society of Thoracic Surgeons Databases |
| Q90368705 | Undiagnosed Systemic Mastocytosis Presenting as Postoperative Distributive Shock: A Case Report |
| Q37161839 | Unique cause of right hemispheric syndrome: Embolism of myocardium after open septal myectomy. |
| Q67759372 | Unruptured Noncoronary Sinus of Valsalva Aneurysm: Preoperative Characterization by Transesophageal Echocardiography |
| Q44550833 | Untreated aortic valve stenosis identified at the time of coronary artery bypass grafting: thresholds associated with adverse prognosis |
| Q40935708 | Urgent Ultrasound-Guided Bilateral Stellate Ganglion Blocks in a Patient With Medically Refractory Ventricular Arrhythmias |
| Q71566501 | Use of coronary artery bypass surgical procedure and coronary angioplasty in treatment of coronary artery disease: changes during a 10-year period at Mayo Clinic Rochester |
| Q54143068 | Use of internal mammary artery grafts for multiple coronary artery bypasses. |
| Q70981599 | Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery |
| Q46723837 | Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy |
| Q69616795 | Utility of temporary atrial epicardial electrodes in postoperative pediatric cardiac patients |
| Q42970382 | Validation of clinical scores predicting severe acute kidney injury after cardiac surgery |
| Q61648566 | Valve Morphology in Antiphospholipid Antibody Syndrome: Echocardiographic Features |
| Q47897922 | Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis |
| Q51686902 | Valve-preserving aortic root reconstruction: a comparison of techniques. |
| Q28247282 | Valvular heart disease associated with fenfluramine-phentermine |
| Q67720860 | Valvular heart disease in four patients with Maroteaux-Lamy syndrome |
| Q44247014 | Valvular heart disease in patients taking pergolide |
| Q38076477 | Valvular heart disease in patients with osteogenesis imperfecta |
| Q61648609 | Valvular heart operation in patients with previous mediastinal radiation therapy |
| Q52251982 | Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: a 23-year population-based study. |
| Q33603848 | Variability in data: the Society of Thoracic Surgeons National Adult Cardiac Surgery Database |
| Q44301106 | Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted? |
| Q92959190 | Vascular Rings in Adults: Outcome of Surgical Management |
| Q68032442 | Vasoconstriction to hypoxia of the human internal mammary artery |
| Q61648449 | Ventricular Tachycardia in Hypertrophic Cardiomyopathy With Apical Aneurysm |
| Q53387394 | Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement. |
| Q47888107 | Very long-term survival and durability of mitral valve repair for mitral valve prolapse |
| Q61648250 | Vitamin C for Vasoplegia After Cardiopulmonary Bypass |
| Q83514012 | WITHDRAWN: Erratum to "Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia" [ATH 154 (2001) 195-201] |
| Q50105867 | What Constitutes Experience in Surgical Treatment of Valve Disease and How Important Is It? |
| Q44514669 | What are patients really telling us? Comparison of survey responses and the medical record in cardiovascular surgical patients |
| Q53969151 | What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). |
| Q39299537 | What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation? |
| Q53443121 | What is the optimal myocardial preservation strategy at re-operation for aortic valve replacement in the presence of a patent internal thoracic artery? |
| Q61648251 | What is the role of apical ventriculotomy in children and young adults with hypertrophic cardiomyopathy? |
| Q53676262 | When should a mechanical tricuspid valve replacement be considered? |
| Q44042990 | When should prophylactic maze procedure be considered in patients undergoing mitral valve surgery? |
| Q37822029 | When to intervene for asymptomatic mitral valve regurgitation |
| Q53458271 | Why we need more septal myectomy surgeons: An emerging recognition. |
| Q47613563 | Women with hypertrophic cardiomyopathy have worse survival. |
| Q72747770 | [Endothelial function and coronary vasospasm after heart surgery] |
| Q73013777 | [Experimental methods in the study of endothelial function] |
| Q71816583 | [Ischemia-reperfusion lesion. Physiopathologic aspects and the importance of the endothelial function] |
| Q28298419 | ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Perc |
Search more.